Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.

Bengaluru: Commuting on the 6km Bommasandra-Jigani industrial corridor, home to some of the city's largest pharmaceutical and ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

Lehigh Carbon Community College is poised to become the hub of pharmaceutical workforce development in Pennsylvania. Following an announcement by Gov. Josh Shapiro at the Da Vinci Science Center, ...

By Dare Ehigie AUSTIN, TX, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- A peer-reviewed study suggests that ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this ...

SanegeneBio and Genentech entered a global licensing agreement aimed at advancing an RNA interference (RNAi) therapeutic ...

British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, ...

Expert said, the policy encourages industry players to innovate beyond sourcing and consumption, therefore widening ...